International League Athlete Sanctioned
Sport Integrity Australia acknowledges the decision of the French Anti-Doping Agency, Agence Francaise De Lutte Contre Le Dopage (AFLD) to impose a three-year period of Ineligibility on Australian athlete Brock Hamill for the Presence of a Prohibited Substance, namely Testosterone and its metabolites.
Mr Hamill, a rugby league player for the PIA XIII Baroudeur team in the Elite 1 Championship at the time, returned an Adverse Analytical Finding (AAF) from an In-Competition doping control test on 9 December 2023.
Mr Hamill’s sample was analysed by the AFLD and the presence of Testosterone and its metabolites were detected.
The substance Testosterone is listed under Class S1.1. Anabolic Androgenic Steroids (AAS) under the World Anti-Doping Code – International Standard – Prohibited List – 2023 and is a Non-Specified Substance, prohibited at all times.
AFLD imposed a three-year period of Ineligibility on Mr Hamill commencing on 29 February 2024.
Mr Hamill is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 28 February 2027. He is also not permitted to compete in a non-Signatory professional league or Event organised by a non-Signatory International Event organisation or a non-Signatory national-level event organisation.
Additional information on the Prohibited Substance
The use of testosterone has been shown to cause health side effects which include, an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease, infertility, acne, kidney and prostate cancer can also result from the use of this substance. The use of testosterone has also been proven to increase the user’s likelihood of experiencing depression, aggression and psychosis.
Anabolic Androgenic Steroids (AAS) are a group of synthetic drugs that are similar to the male sex hormone testosterone. They regulate the development and maintenance of male characteristics having a tissue building and masculinising effect.
